TG
KLRS

TCW Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

TCW Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,768
Closed -$951K – 365
2021
Q1 		$951K Sell
1,768
-7,629
-81% -$4.1M 0.01% 294
2020
Q4 		$8.31M Buy
+9,397
New +$8.31M 0.07% 147